Strategic Wealth Advisors Group LLC acquired a new stake in shares of Express Scripts Holding Company (NASDAQ:ESRX) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquired 13,794 shares of the company’s stock, valued at approximately $880,000.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Dodge & Cox grew its position in Express Scripts Holding by 25.7% during the 2nd quarter. Dodge & Cox now owns 36,188,517 shares of the company’s stock worth $2,310,275,000 after purchasing an additional 7,388,021 shares during the last quarter. Pzena Investment Management LLC purchased a new stake in shares of Express Scripts Holding in the 2nd quarter valued at $181,234,000. Renaissance Technologies LLC boosted its holdings in Express Scripts Holding by 9,353.3% during the first quarter. Renaissance Technologies LLC now owns 1,308,239 shares of the company’s stock worth $86,226,000 after buying an additional 1,294,400 shares in the last quarter. Baupost Group LLC MA purchased a new stake in Express Scripts Holding during the first quarter worth $80,978,000. Finally, Northern Trust Corp boosted its holdings in Express Scripts Holding by 12.2% during the second quarter. Northern Trust Corp now owns 11,068,777 shares of the company’s stock worth $706,629,000 after buying an additional 1,206,980 shares in the last quarter. Institutional investors own 88.67% of the company’s stock.
Shares of Express Scripts Holding Company (ESRX) traded up 5.53% on Friday, reaching $62.19. 9,086,110 shares of the company traded hands. The company has a market capitalization of $35.92 billion, a PE ratio of 10.79 and a beta of 0.88. Express Scripts Holding Company has a 52-week low of $55.80 and a 52-week high of $77.50. The firm has a 50-day moving average of $61.07 and a 200-day moving average of $61.95.
Express Scripts Holding (NASDAQ:ESRX) last issued its quarterly earnings results on Tuesday, October 24th. The company reported $1.90 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $1.90. Express Scripts Holding had a return on equity of 25.46% and a net margin of 3.64%. The business had revenue of $24.68 billion for the quarter, compared to the consensus estimate of $25.68 billion. During the same quarter in the prior year, the business posted $1.74 earnings per share. The firm’s quarterly revenue was down 2.9% compared to the same quarter last year. On average, equities research analysts forecast that Express Scripts Holding Company will post $7.00 earnings per share for the current fiscal year.
In other Express Scripts Holding news, VP Everett Neville sold 1,163 shares of Express Scripts Holding stock in a transaction dated Wednesday, August 23rd. The stock was sold at an average price of $61.48, for a total transaction of $71,501.24. Following the completion of the transaction, the vice president now owns 18,232 shares in the company, valued at approximately $1,120,903.36. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Phyllis S. Anderson sold 578 shares of Express Scripts Holding stock in a transaction that occurred on Friday, September 8th. The stock was sold at an average price of $63.13, for a total transaction of $36,489.14. Following the transaction, the vice president now directly owns 10,530 shares in the company, valued at approximately $664,758.90. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 5,641 shares of company stock valued at $357,317. 0.68% of the stock is owned by corporate insiders.
ESRX has been the subject of a number of research analyst reports. Jefferies Group LLC set a $72.00 price objective on shares of Express Scripts Holding and gave the stock a “buy” rating in a research report on Tuesday, August 29th. Zacks Investment Research lowered shares of Express Scripts Holding from a “buy” rating to a “sell” rating in a research note on Tuesday. UBS AG lowered shares of Express Scripts Holding from a “market perform” rating to an “underperform” rating in a research note on Monday, October 9th. Royal Bank Of Canada set a $66.00 price objective on shares of Express Scripts Holding and gave the stock a “hold” rating in a report on Wednesday. Finally, Raymond James Financial, Inc. reissued an “underperform” rating on shares of Express Scripts Holding in a report on Monday, October 9th. Seven investment analysts have rated the stock with a sell rating, eleven have issued a hold rating, six have given a buy rating and one has issued a strong buy rating to the stock. Express Scripts Holding currently has an average rating of “Hold” and a consensus price target of $69.56.
ILLEGAL ACTIVITY WARNING: This piece was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece on another publication, it was stolen and republished in violation of US & international trademark & copyright laws. The correct version of this piece can be viewed at https://www.dispatchtribunal.com/2017/10/28/strategic-wealth-advisors-group-llc-takes-position-in-express-scripts-holding-company-esrx.html.
Express Scripts Holding Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.